Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30 Clinical Trial Optional)

Grant Name
Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30 Clinical Trial Optional)
Funder
U.S. Department of Health and Human Services
Country or Region
United States
Research Field
Medicine, General Medicine
Biochemistry, Genetics and Molecular Biology, General Biochemistry,Genetics and Molecular Biology
Deadline
May 27, 2022 (Expired)
Grant Size
Up to 750,000 USD
Contact Info
Gao,Hongwei hongwei.gao@nih.gov
Grant Number
PAR-20-115
Description
The purpose of this Funding Opportunity Announcement (FOA) is to transition the core resources and biomedical research activities of Centers of Biomedical Research Excellence (COBRE) into independence and sustainability.

Funding resources

Purdue Grant Writing Lab: Introduction to Grant Writing Open Link
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal Open Link

Quick share


Add deadline to calendar

May 27, 2022

Have a funding opportunity that you want to list here?

Submit the grant details to support@peeref.com for review and listing.


Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Related opportunities

Australian National Aged Care Classification (AN-ACC) Transition Fund
Aged Care 30-Jun-2024 $55,440,000.00
Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Not Allowed)
Health Sep 13, 2024 12:00:00 AM EDT $500,000
European Partnership: One Health Anti-Microbial Resistance
Antimicrobial resistance 2024-09-25 €100000000
Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (UT1/UT2) Clinical Trial Not Allowed
Health Jun 06, 2025 12:00:00 AM EDT $295,924
Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed)
Health Jun 06, 2025 12:00:00 AM EDT $295,924
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
Health Sep 05, 2025 12:00:00 AM EDT $1,838,436
HEAL Commercialization Readiness Pilot (CRP) Program: Embedded Entrepreneurs for Small Businesses in Pain Management (SB1 Clinical Trial Not Allowed)
Health Sep 05, 2025 12:00:00 AM EDT $400,000
MOMENTUM (Moving Integrated, Quality Maternal, Newborn, and Child Health and Family Planning and Reproductive Health Services to Scale)
Medicine September 30, 2025 Up to 200,000,000 USD
MRFF 2022 Frontier Health and Medical Research Grant Opportunity
Health and Medical Research 31-Mar-2026 $400,000,000.00
Innovative Health Practices
Science and Technology and other Researc... Feb 20, 2028 12:00:00 AM EST $1,000,000,000